Biobot Analytics

Cambridge, MA · Founded 2017 · Privately Held (backing)

Developer of a wastewater analysis tool designed to deliver untapped insights into human health and behavior. Biobot Analytics is based in Cambridge, MA and was founded in 2017. Its last reported valuation was $127 million in Oct 2021. It has raised $41.2 million across 3 recorded rounds; the latest was a $13.5 million early-stage round in May 2025.

Last reported valuation
$126.8M
Oct 2026
Priced at
—
Total raised
$41.2M
Last round
Early Stage VC
May 2025
What is Biobot Analytics worth?
$126.8Mlast reported valuation · Oct 2026

Biobot Analytics's last reported valuation, Oct 2021. Nothing priced has surfaced since.

Free account
More of Biobot Analytics with a free account
  • ·The complete investor list: 38 names
  • ·Watch Biobot Analytics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Biobot Analytics funding history

3 rounds
DateRoundRaisedPost-money
May 2025Early Stage VC$13.5M▮
Jul 2021Early Stage VC$20.8M▮
Apr 2020Early Stage VC$6.7M▮
Unlock post-money valuations

Membership and data by Private Market View

Biobot Analytics valuation

Biobot Analytics's last reported valuation was $127 million in Oct 2021. No priced round, secondary trade or fund mark has surfaced since.

How much has Biobot Analytics raised?

Biobot Analytics has raised $41.2 million across 3 recorded rounds since 2020. The largest was a $6.7 million early-stage round in Apr 2020; the most recent was a $13.5 million early-stage round in May 2025.

Biobot Analytics has filed 4 Form Ds with the SEC since 2020, most recently in Jun 2025 ($13.5 million sold to 46 investors).

How Biobot Analytics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Biobot Analytics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Biobot Analytics

What is Biobot Analytics worth?
Biobot Analytics is valued at $126.8M as of Oct 2026. Biobot Analytics's last reported valuation, Oct 2021. Nothing priced has surfaced since.
How much has Biobot Analytics raised?
Biobot Analytics has raised $41.2M in total funding across 3 recorded rounds.
When did Biobot Analytics last raise?
Biobot Analytics last raised in May 2025 (Early Stage VC), raising $13.5M.